SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Cistron Biotechnology(CIST)$.30 -- Ignore unavailable to you. Want to Upgrade?

To: Rudy Saucillo who wrote (2300)6/8/1999 1:59:00 PM
From: Steve Harmon  Read Replies (1) | Respond to of 2742
 
We could sell for 60-75 cents easy. Easily done since last June 1998 with a easy phone call. Without paying commissions and more dilution and 1 year paid vacations!

That would have been for our cash only! Then a spinoff of IL-1 technology could be in shareholders pockets for FREE.

The spinoff of IL-1 was presented to Bruce Galton more than a year ago by Bluestone Capital. It was turned down.




To: Rudy Saucillo who wrote (2300)6/8/1999 3:13:00 PM
From: Walter Morton  Respond to of 2742
 
So, anybody that is interested in buying CIST is not interested in the $31 million + royalties agreement with PMC?

If somebody does buy CIST because of the $31 million + royalties agreement, how much should they be willing to pay for that part of CIST's potential?

By the way, what makes you think the $31 million + royalties agreement is worthless and impossible to obtain?



HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News